AIM 01 July 2009 ? NOTICE (470) 01/07/2009 7:00am CANCELLATION OF ADMISSION OF SECURITIES TO TRADING ON AIM ENTELOS INC. At the request of the...
L Entelos, Inc. ("Entelos" or the "Company") today announces that the Company's shareholders overwhelmingly voted to approve a proposal to de-list...
L Entelos, Inc. ("Entelos" or the "Company") (LSE: ENTL), a leader in predictive disease simulation for pharmaceutical, health-care and consumer...
L Entelos, Inc. ("Entelos" or the "Company") today announced that it intends to seek stockholder approval to cancel the trading of its shares of...
L Entelos, Inc. Management Changes Entelos, Inc. ("Entelos" or the "Company") announces changes to its senior management team. Jim Neal is...
L On December 21, 2007, Entelos, Inc. ("Entelos" or the "Company") entered into a debt financing agreement with Imperium Master Fund, LTD...
L Entelos, Inc. Imperium Debt Financing On December 21, 2007, Entelos, Inc. ("Entelos" or the "Company") entered into a debt financing agreement...
L The Hamner Institutes for Health Sciences and Entelos, Inc. announced they have established a partnership to create a computer model of liver...
Entelos Inc. (ENTL.LN), which makes software that lets pharmaceutical companies run "virtual" drug trials using computers, said Wednesday it...
L Entelos, Inc. (LSE: ENTL), a leader in predictive disease simulation for pharmaceutical, health-care and consumer products applications...
L In accordance with Rule 17 of the AIM rules for Companies, Entelos, Inc. (LSE: ENTL) announces that on January 21, 2009 it received a...
Entelos, Inc. (LSE: ENTL) announces that it has repurchased a total of 3.9 million shares of its common stock (representing approximately 5.6% of...
Entelos, Inc. (LSE: ENTL), the leader in predictive disease simulation for pharmaceutical, health-care and consumer products applications, today...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.